Minimal Access Surgical Technique (MAST) in Obese Patients in Degenerative Lumbar Disease. A Prospective Long-term Evaluation
Completed
- Conditions
- Degenerative Lumbar Disease
- Registration Number
- NCT01259960
- Lead Sponsor
- Dr. Wolfgang Senker
- Brief Summary
Being confronted more and more with obese as well as older patients, minimally invasive surgery is said to keep the surgical trauma low. The prospective long-term evaluation is the continuous monitoring of patients undergoing lumbar minimally invasive fusion surgery and analyzing the effect of body mass index (BMI) and wound healing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 187
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Liquor leakage between operation and hosital discharge of patient Operation related complications between operation and hospital discharge of patient Post operative fever between operation and hospital discharge of patient
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the long-term outcomes of MAST in obese patients with degenerative lumbar disease compared to traditional open fusion?
How does BMI affect wound healing and surgical trauma in minimally invasive lumbar fusion as observed in NCT01259960?
Are there specific biomarkers that correlate with successful MAST outcomes in elderly obese patients with spinal degeneration?
What adverse events are associated with MAST in high BMI patients and how do they compare to standard surgical approaches?
How does the MAST technique influence recovery rates and complication management in degenerative lumbar disease compared to conventional methods?
Trial Locations
- Locations (1)
General Hospital
🇦🇹Amstetten, Austria
General Hospital🇦🇹Amstetten, Austria